Dr. Colleen Gruenwald, CCP.
Dr. Colleen Gruenwald, Director of Cardiovascular Perfusion Services, has had a long and distinguished career at the Hospital for Sick Children in Ontario, Canada. She is one of the pioneers in the use of novel technology like EXCOR and NOVALUNG devices. Dr. Gruenwald is one of the world’s leading experts on the use of Extracorporeal Membrane Oxygenator (ECMO) support devices for children and adults . She has also innovated on new techniques for LA decompression for Heart failure.
Dr. Christof Schmid
Dr. Schmid is one of the leading authorities in the use of Ventricular Assisted devices in Europe, including Internal Implantable Pumps like INCOR and External Pumps like EXCOR. He possesses vast experience in the field of Cardiac Surgery and Assisted Perfusion in a variety of clinical situations including medical and surgical Heart failure. Dr. Schmid has had the distinction of working with the world famous pioneering Heart Surgeon, Dr. Norman Schumway in 1986.He took over as Adjunct Professor and Director of Heart Failure Program and Cardiovascular Surgery at the University of Regensberg Germany in 2001. He has a number of scientific articles on Ventricular Assisted devices and Heart Transplant to his credit.
Dr. James W. Long,
Director of the INTEGRIS Advanced Cardiac Care & Medical Director of INTEGRIS Nazih Zuhdi Transplant Institute, Dr. James Long is a world-renowned Cardiac Surgeon in the new expanding Field of Mechanical Assist devices like HEARTMATE-2 for Heart failure .He had a distinguished career in Heart Surgery in the US over the last 30 years. Dr. Jim Long joined the staff of INTEGRIS Baptist Medical Center in Oklahoma City in January, 2008, to work with the INTEGRIS Nazih Zuhdi Transplant Institute and the cardiovascular program as Director of INTEGRIS Advanced Cardiac Care. In December, 2010, Dr. Long was also named Medical Director of the Nazih Zuhdi Transplant Institute.
Prior to this, he founded and directed the Utah Artificial Heart Program at Intermountain HealthCare in Salt Lake City, Utah and was a Clinical Professor of Surgery and Bioengineering at the University of Utah.
As a Cardiothoracic Surgeon, his work on advanced heart failure has included high risk heart surgery, advanced mechanical circulatory support and heart transplantation. His clinical experience with blood pumps began as an investigator with the first ever implantable heart pump approved by the FDA. His program went on to become the leading enrolling center for the landmark clinical trial that led to expanded use of heart pumps for long-term, permanent use. He has been a leader with initiatives to improve outcomes, quality of life and cost effectiveness.
His experience includes laboratory research with blood pumps. Moreover, his innovation and leadership were instrumental in the development of a next-generation Left Ventricular Assist Device (LVAD) which is nearing clinical trials in the US.
Dr. Long has contributed extensively with knowledge and education to advancements in this field. In the past, he has served as president of ASAIO (The American Society for Artificial Internal Organs).
Among his personal interests is international humanitarian medical work, most often in Calcutta, India, where he oversees the Mission of Mercy Hospital network and Nursing School.
Dr. Valluvan Jeevanandam, MD.
Professor of Surgery, Chief, Cardiac and Thoracic Surgery, University of Chicago, Dr. Valluvan Jeevanandam specializes in the surgical management of heart failure and is an expert in high-risk cardiac surgery. He has performed more than 1000 heart transplants including the total artificial heart and countless cardiac surgery procedures like Transmyocardial Laser Revascularization, Complex Valve Reconstruction and Minimally Invasive Coronary Artery Bypass Graft Surgery.Dr. Jeevanandam has a special interest in treating patients traditionally considered inoperable. He has repaired damaged hearts in several patients awaiting transplant, enabling those patients to forgo transplantation. He also has successfully performed transplants involving patients who do not fit the standard criteria for transplants. Additionally, Dr. Jeevanandam has received national attention for his skill in performing bloodless cardiac surgery, which requires the use of precise surgical techniques to minimise blood-loss during the procedure, sparing the need for blood transfusion.
He is a pioneer in the field of mechanical circulatory assist devices. In October 2000, he was the first surgeon in the world to successfully implant the CardioVad, a revolutionary, permanent circulatory assist device that boosts heart function in patients with severe heart failure who are not candidates for transplant. He continues to be a recognised leader in the field of advanced heart failure and currently serves on the FDA Device Panel.
Dr. Jeevanandam is a world-renowned surgeon, having started high risk and cardiac assist programs in countries including China, India, the Middle East and South America.